Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.38",
    "chg": 0.83,
    "chgp": "6.13%",
    "dir": 1,
    "prev_price": "13.55",
    "mcapval": "1,326.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE312C01025",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "27.72 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Syncom Formulations (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-syncom-formulations-india-ltd-fallingrising-3829354",
        "imagepath": "",
        "date": "2026-02-10 00:19:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Syncom Formulations demonstrated a robust recovery on 09-Feb, gaining ₹0.83 or 6.13% by 08:52 PM. This rise follows a brief period of consecutive falls, signalling a potential trend reversal. The stock’s performance today notably outpaced its sector by 4.55%, indicating renewed investor interest and confidence relative to its immediate market peers.</p>\n<p>Examining the moving averages provides further insight into the stock’s technical positioning. The current price stands above the 5-day, 20-day, and 50-day moving averages, suggesting short to medium-term bullish momentum. However, it remains below the longer-term 100-day and 200-day averages, indicating that while recent momentum is positive, the stock has yet to fully overcome long..."
      },
      {
        "title": "When is the next results date for Syncom Formulations (India) Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-syncom-formulations-india-ltd-3823196",
        "imagepath": "",
        "date": "2026-02-05 23:18:01",
        "description": "The next results date for Syncom Formulations (India) Ltd is scheduled for 12 February 2026...."
      },
      {
        "title": "Syncom Formulations (India) Ltd Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3818424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyncomFormulati_gapup_3818424.png",
        "date": "2026-02-03 11:06:45",
        "description": "Syncom Formulations (India) Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 5.0% higher than its previous close, reflecting a strong start and positive sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3817713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyncomFormulati_mojoScore_3817713.png",
        "date": "2026-02-03 10:14:03",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 08 August 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 03 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd Hits Day High with Strong Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-day-high-with-strong-intraday-surge-3814494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyncomFormulati_priceRelatedfactors_3814494.png",
        "date": "2026-02-01 11:06:46",
        "description": "Syncom Formulations (India) Ltd recorded a robust intraday performance on 1 Feb 2026, surging to its day high with a notable 7.69% gain, significantly outpacing the broader market and its sector peers."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3801382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_mojoScore_3801382.png",
        "date": "2026-01-23 10:10:54",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd Hits 52-Week Low at Rs.11.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-52-week-low-at-rs1152-3800161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3800161.png",
        "date": "2026-01-22 11:01:13",
        "description": "Syncom Formulations (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.11.52 today, marking a significant decline amid broader market movements and company-specific performance trends."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amid-market-downturn-3796257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3796257.png",
        "date": "2026-01-20 11:07:23",
        "description": "Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.12.3 today, marking a significant decline in its share price amid broader market pressures and company-specific performance trends."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amidst-market-downturn-3794569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3794569.png",
        "date": "2026-01-19 11:42:09",
        "description": "Syncom Formulations (India) Ltd’s stock touched a fresh 52-week low of Rs.12.75 today, marking a significant decline amid broader market pressures and company-specific performance trends. The stock’s fall contrasts with the broader Sensex, which remains near its yearly highs despite recent volatility."
      }
    ],
    "total": 247,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Holding 5/2025-26 Board Meeting For Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 31St December 2025.",
      "datetime": "04-Feb-2026",
      "details": "Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 5/2025-26 Meeting of the Board of Directors of the Company is scheduled to be held on Thursday the 12th day of February 2026 at 3:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Jan-2026",
      "details": "Certificate for compliance of regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Jan-2026",
      "details": "Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) regulation 2018 for the quarter ended 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Syncom Formulations (India) Ltd falling/rising?

2026-02-10 00:19:43

Recent Price Movement and Market Context

Syncom Formulations demonstrated a robust recovery on 09-Feb, gaining ₹0.83 or 6.13% by 08:52 PM. This rise follows a brief period of consecutive falls, signalling a potential trend reversal. The stock’s performance today notably outpaced its sector by 4.55%, indicating renewed investor interest and confidence relative to its immediate market peers.

Examining the moving averages provides further insight into the stock’s technical positioning. The current price stands above the 5-day, 20-day, and 50-day moving averages, suggesting short to medium-term bullish momentum. However, it remains below the longer-term 100-day and 200-day averages, indicating that while recent momentum is positive, the stock has yet to fully overcome long...

Read full news article

When is the next results date for Syncom Formulations (India) Ltd?

2026-02-05 23:18:01

The next results date for Syncom Formulations (India) Ltd is scheduled for 12 February 2026....

Read full news article

Syncom Formulations (India) Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 11:06:45

Syncom Formulations (India) Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 5.0% higher than its previous close, reflecting a strong start and positive sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-02-03 10:14:03

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 08 August 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 03 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Syncom Formulations (India) Ltd Hits Day High with Strong Intraday Surge

2026-02-01 11:06:46

Syncom Formulations (India) Ltd recorded a robust intraday performance on 1 Feb 2026, surging to its day high with a notable 7.69% gain, significantly outpacing the broader market and its sector peers.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-01-23 10:10:54

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Syncom Formulations (India) Ltd Hits 52-Week Low at Rs.11.52

2026-01-22 11:01:13

Syncom Formulations (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.11.52 today, marking a significant decline amid broader market movements and company-specific performance trends.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amid Market Downturn

2026-01-20 11:07:23

Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.12.3 today, marking a significant decline in its share price amid broader market pressures and company-specific performance trends.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Market Downturn

2026-01-19 11:42:09

Syncom Formulations (India) Ltd’s stock touched a fresh 52-week low of Rs.12.75 today, marking a significant decline amid broader market pressures and company-specific performance trends. The stock’s fall contrasts with the broader Sensex, which remains near its yearly highs despite recent volatility.

Read full news article

View All News